Boston Scientific (BSX) to Acquire Relievant Medsystems for Over $850 Million
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
JPMorgan on Boston Scientific (BSX) Investor Day Update: 'reinforces our bullish view on Boston'
September 20, 2023 10:52 AM EDTJPMorgan analyst Robbie Marcus reiterated an Overweight rating on Boston Scientific (NYSE: BSX)
The analyst comments "Management kicked off the Boston Scientific biennial analyst day with an update to its LRP (long range plan) for 2024-2026 that now points towards: (1) sales CAGR of +8-10%... More
RBC on Boston Scientific (BSX) Long-Range Plan Released Earlier at Investor Day, 'we are encouraged
September 20, 2023 10:32 AM EDTRBC Capital analyst Shagun Singh reiterated an Outperform rating and $58.00 price target on Boston Scientific (NYSE: BSX).
The analyst comments "BSX released its 2024-2026 long-range plan (LRP) at its Investor Day, which came in above expectations. This morning (9/20) BSX issued its 2024-26 LRP. It included organic... More
